Almonty's Buyback Meets a Market That Won't Wait for News

Almonty shares fell 11% over seven sessions despite a Jefferies buy rating and surging revenue, as investors await proof its buyback is executed.

Almonty finds itself in an unusual position for a company with freshly minted operational momentum: its share price is doing the talking, and not always in a language the fundamentals can translate. Over the past seven trading sessions the stock has shed 11%, even as it clings to a 7.5% gain on a 30-day view. Friday's session alone brought a 6.1% decline to a close of EUR 13.40, a move commentators have framed as a valuation-driven consolidation rather than a response to any fresh development. Media coverage of the slide found no company-specific catalyst behind it.

That absence of a headline is itself the story. Just days earlier, on September 8, the shares had jumped 10.3% intraday, a rally attributed not to a single announcement but to persistently bullish sentiment around tungsten supply, layered on top of older threads — progress at Sangdong and the buyback authorization approved in August. The pattern is becoming familiar: a fundamental trigger sets off a surge, expectations take over from there, and profit-taking eventually reels in the excess.

The Buyback as a Live Test

Against that backdrop, the repurchase program has shifted from footnote to focal point. Approved by the board on August 17 and running since August 24, it permits Almonty to buy back up to 14,400,000 common shares — roughly 5% of the shares outstanding as of August 14 — through August 24, 2029. What matters now is whether the company actually steps into the market. To date, no executed purchases have been reported.

The mechanics could matter in a float this thin. With only about 5% of shares in free circulation, a consistent buyback would introduce a structural demand component that could register meaningfully, particularly with the stock sitting just 0.5% above its 50-day moving average. A company repurchasing its own equity after a 247% twelve-month run and a quadrupling of quarterly revenue projects confidence — provided the authorization translates into transactions. If it remains paperwork, the potential support effect evaporates.

Jefferies and the Fundamental Backdrop

The bullish case rests on more than buyback mechanics. Jefferies Financial Group initiated coverage on September 2 with a buy rating and a price target of USD 26.25, a level well above current trading and one that assumes operational strength. Curiously, the stock fell 5.2% on the very day that initiation landed — another data point suggesting Almonty's short-term moves often run counter to what the news flow would imply.

The August quarterly results supply the foundation: revenue surged 498%, while adjusted EBITDA swung from negative USD 4.8 million to positive USD 17.6 million. Those figures underpin both the repurchase program and the constructive analyst view. In this reading, the recent pullback looks like a breather after a powerful run rather than a change in direction.

Where the Risk Sits

The bear case is already being priced in. Thirty-day volatility stands at 75%, and an 11% weekly decline with no identifiable trigger exposes how jittery investors have become after the stock's multi-fold advance. An RSI of 43 signals neither oversold conditions nor conviction — more a market unsure of its footing. Should the buyback prove to be an authorization without execution, disappointment could weigh further on the price.

There is also the tungsten price itself. According to the quarterly figures, it was the primary driver of the revenue jump, and it sits outside the company's control. A retreat there would deflate a central growth engine.

Institutional Money, Longer Horizons

While retail traders ride the swings, institutional flows tell a calmer story. The Public Employees Retirement System of Ohio reported a new position of 109,121 Almonty shares for the second quarter, valued at roughly USD 1.81 million. That kind of positioning from a long-horizon pension fund sits awkwardly alongside momentum trading — it suggests part of the market is tracking the tungsten thesis independently of daily noise.

That divergence between short-term nerves and long-term interest is the real theme. Almonty embodies a class of commodity equities benefiting from a structural demand shift — here, the reorientation of Western supply chains away from Chinese dominance in critical metals — whose share prices are nonetheless driven day to day by sentiment, positioning and technical factors largely disconnected from the business itself.

The question is how long those two planes can stay apart before converging. Friday's retreat may be exactly that convergence: a correction of expectations, not a verdict on the underlying operations. For investors treating Almonty as a wager on the critical-materials transition, the challenge is unchanged — separating the noise of daily moves from the signal that matters. The near-term litmus test is concrete: will Almonty report actual buybacks in the coming weeks, or will August 24 remain nothing more than an authorization?